Protagenic Therapeutics Financial Flexibility Index
Protagenic Therapeutics financial flexibility index. Protagenic Therapeutics (PTIX) has a Financial Flexibility Index of -0.06x as of December 2025. Free cash flow of $-410.42K (operating CF $-410.42K minus capex $6.00) represents 0% of total liabilities ($6.82 Million). See PTIX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Protagenic Therapeutics (1995–2025)
Financial flexibility index of Protagenic Therapeutics from 1995 to 2025. Historical Financial Flexibility Index trend for Protagenic Therapeutics across 31 annual periods. Check earnings quality score of Protagenic Therapeutics to evaluate the quality of earnings relative to operating cash generation.
Protagenic Therapeutics Financial Flexibility Index by Year (1995–2025)
Protagenic Therapeutics financial flexibility index by year from 1995 to 2025. Year-by-year free cash flow to debt coverage for Protagenic Therapeutics. For the full cash flow conversion analysis, see Protagenic Therapeutics (PTIX) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.61x | $-4.14 Million | $-4.14 Million | $6.82 Million | ▲ +86.4% |
| 2024 | -4.47x | $-4.22 Million | $-4.22 Million | $942.76K | ▲ +17.5% |
| 2023 | -5.42x | $-3.55 Million | $-3.70 Million | $655.25K | ▼ -204.9% |
| 2022 | -1.78x | $-1.99 Million | $-1.99 Million | $1.12 Million | ▲ +28.9% |
| 2021 | -2.50x | $-2.80 Million | $-2.80 Million | $1.12 Million | ▼ -276.6% |
| 2020 | -0.66x | $-1.35 Million | $-1.35 Million | $2.03 Million | ▼ -101.2% |
| 2019 | -0.33x | $-487.99K | $-487.99K | $1.48 Million | ▲ +72.0% |
| 2018 | -1.18x | $-1.07 Million | $-1.07 Million | $907.77K | ▲ +52.0% |
| 2017 | -2.46x | $-1.38 Million | $-1.38 Million | $561.69K | ▼ -47.6% |
| 2016 | -1.67x | $-1.14 Million | $-1.14 Million | $684.86K | ▼ -210.9% |
| 2015 | -0.54x | $-377.00K | $-378.00K | $704.00K | ▲ +10.5% |
| 2015 | -0.60x | $-377.00K | $-378.00K | $630.00K | ▲ +76.0% |
| 2014 | -2.50x | $-789.00K | $-790.00K | $316.00K | ▲ +0.0% |
| 2013 | -2.50x | $-789.00K | $-790.00K | $316.00K | ▼ -13910.0% |
| 2012 | -0.02x | $-324.00K | $-324.00K | $18.18 Million | ▲ +98.2% |
| 2010 | -1.00x | $-11.21 Million | $-11.25 Million | $11.17 Million | ▼ -728.0% |
| 2009 | -0.12x | $-2.33 Million | $-3.02 Million | $19.25 Million | ▼ -145.8% |
| 2008 | 0.26x | $6.38 Million | $4.36 Million | $24.11 Million | ▲ +138.0% |
| 2007 | -0.70x | $-4.94 Million | $-5.21 Million | $7.10 Million | ▼ -395.1% |
| 2006 | 0.24x | $1.01 Million | $931.00K | $4.27 Million | ▲ +150.7% |
| 2005 | -0.47x | $-44.00K | $-44.00K | $94.47K | ▼ -133.2% |
| 2004 | -0.20x | $-842.00K | $-842.00K | $4.21 Million | ▼ -152.2% |
| 2003 | 0.38x | $3.35 Million | $1.87 Million | $8.76 Million | ▼ -19.8% |
| 2002 | 0.48x | $4.13 Million | $2.35 Million | $8.65 Million | ▼ -12.5% |
| 2001 | 0.55x | $5.29 Million | $1.50 Million | $9.71 Million | ▼ -26.7% |
| 2000 | 0.74x | $6.74 Million | $3.51 Million | $9.06 Million | ▲ +1643.2% |
| 1999 | 0.04x | $412.00K | $331.00K | $9.66 Million | ▲ +187.0% |
| 1998 | -0.05x | $-369.00K | $-434.00K | $7.53 Million | ▼ -118.4% |
| 1997 | 0.27x | $657.00K | $-2.20 Million | $2.47 Million | ▲ +23.6% |
| 1996 | 0.22x | $1.19 Million | $-230.00K | $5.53 Million | ▲ +5.2% |
| 1995 | 0.20x | $730.00K | $-600.00K | $3.57 Million | — |